Published in Early Interv Psychiatry on May 22, 2013
New drug developments in psychosis: Challenges, opportunities and strategies. Prog Neurobiol (2016) 0.77
The "polyenviromic risk score": Aggregating environmental risk factors predicts conversion to psychosis in familial high-risk subjects. Schizophr Res (2016) 0.77
Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research. Curr Behav Neurosci Rep (2015) 0.75
Premorbid multivariate prediction of adult psychosis-spectrum disorder: A high-risk prospective investigation. Schizophr Res (2015) 0.75
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42
A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol (2002) 15.31
Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull (2003) 7.11
Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry (2012) 5.45
A life course approach to chronic disease epidemiology. Annu Rev Public Health (2005) 4.17
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88
Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res (2003) 3.86
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2010) 3.82
At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry (2011) 3.66
Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophr Bull (2010) 3.21
The genetics of schizophrenia. PLoS Med (2005) 2.56
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry (2010) 2.54
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry (2009) 2.17
Should attenuated psychosis syndrome be a DSM-5 diagnosis? Am J Psychiatry (2011) 2.02
Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry (2000) 1.77
Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry (2005) 1.76
The personal meaning of recovery among individuals treated for a first episode of psychosis. Psychiatr Serv (2012) 1.71
A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res (2010) 1.68
Five steps to conducting a systematic review. J R Soc Med (2003) 1.64
Bizarre delusions and DSM-III-R schizophrenia. Am J Psychiatry (1992) 1.56
Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry (2009) 1.56
A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophr Res (2011) 1.44
Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biol Psychiatry (2009) 1.44
Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. Schizophr Bull (2011) 1.36
The Copenhagen High-Risk Project, 1962-86. Schizophr Bull (1987) 1.34
Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments. Schizophr Res (2008) 1.32
The case for heterogeneity in the etiology of schizophrenia. Schizophr Res (1995) 1.28
Neurobehavioral deficits in offspring of schizophrenic parents: liability indicators and predictors of illness. Am J Med Genet (2000) 1.19
Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. J Clin Psychiatry (2010) 1.13
Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Med (2006) 1.13
Whither the attenuated psychosis syndrome? Schizophr Bull (2012) 1.12
Family and twin strategies as a head start in defining prodromes and endophenotypes for hypothetical early-interventions in schizophrenia. Schizophr Res (2001) 1.12
Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophr Res (2010) 1.08
Functional imaging as a predictor of schizophrenia. Biol Psychiatry (2006) 1.07
Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des (2012) 1.05
Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? World Psychiatry (2011) 1.04
Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophr Bull (2007) 1.02
Global attentional deviance as a marker of risk for schizophrenia: specificity and predictive validity. J Abnorm Psychol (1985) 1.02
Early and broadly defined psychosis risk mental states. Schizophr Res (2010) 1.01
Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study. World Psychiatry (2004) 1.01
Multivariate prediction of emerging psychosis in adolescents at high risk for schizophrenia. Schizophr Res (2012) 1.01
Neurobiologic antecedents of schizophrenia in children. Evidence for an inherited, congenital neurointegrative defect. Arch Gen Psychiatry (1977) 1.01
The concept of population prevention: application to schizophrenia. Schizophr Bull (2003) 0.98
A multivariate prediction model of schizophrenia. Schizophr Bull (2002) 0.97
Glycine treatment of the risk syndrome for psychosis: report of two pilot studies. Eur Neuropsychopharmacol (2012) 0.97
Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome. J Psychiatr Res (2011) 0.97
Schizotypal components in people at high risk of developing schizophrenia: early findings from the Edinburgh High-Risk Study. Br J Psychiatry (2002) 0.90
The four dimensions: a model for the social aetiology of psychosis. Br J Psychiatry (2011) 0.90
Can clinicians predict psychosis in an ultra high risk group? Aust N Z J Psychiatry (2010) 0.88
The New York High-Risk Project: a followup report. Schizophr Bull (1987) 0.88
An integrated psychobiological predictive model of emergent psychopathology among young relatives at risk for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.87
Predicting the risk of psychosis onset: advances and prospects. Early Interv Psychiatry (2012) 0.87
Infant predictors of the longitudinal course of schizophrenic development. Schizophr Bull (1987) 0.87
Adult outcomes of high-risk children: differential effects of town and kibbutz rearing. Schizophr Bull (1985) 0.87
The Edinburgh High Risk Study: current status and future prospects. World Psychiatry (2003) 0.87
Specificity of developmental precursors to schizophrenia and affective disorders. Schizophr Res (1999) 0.86
Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention. Neuropsychiatry (London) (2012) 0.86
High-risk research in schizophrenia: a summary of what has been learned. J Psychiatr Res (1987) 0.85
Diagnosing delusions: a review of inter-rater reliability. Schizophr Res (2006) 0.84
Early prodromal symptoms can predict future psychosis in familial high-risk youth. J Psychiatr Res (2011) 0.83
MMPI variables predictive of schizophrenia in the Copenhagen High-Risk Project: a 25-year follow-up. Acta Psychiatr Scand (1999) 0.82
Biomarkers in schizophrenia: we need to rebuild the Titanic. World Psychiatry (2011) 0.82
Looking for a "biological test" to diagnose"schizophrenia": are we chasing red herrings? World Psychiatry (2011) 0.81
Psychometric validation of psychiatric diagnoses in the New York High-Risk Study. Psychiatry Res (1987) 0.80
Psychometric deviance in offspring at risk for schizophrenia: I. Initial delineation of a distinct subgroup. Psychiatry Res (1990) 0.80
Infants at risk for schizophrenia. The Jerusalem Infant Development Study. Arch Gen Psychiatry (1981) 0.80
Assessing the predictive value of teacher reports in a high risk sample for schizophrenia: a ROC analysis. Schizophr Res (1995) 0.80
Swedish high-risk study: sample characteristics at age 6. Schizophr Bull (1987) 0.79
A new MMPI-derived indicator of liability to develop schizophrenia: evidence from the New York High-Risk Project. Assessment (2001) 0.77
On the application of genetic expectancies as age-specific base rates in the study of human behavior disorders. Psychol Bull (1957) 0.77
Psychometric deviance in offspring at risk for schizophrenia: II. Resolving heterogeneity through admixture analysis. Psychiatry Res (1990) 0.76
Recall of obstetric events by mothers of schizophrenic patients. Psychol Med (1998) 0.76
A longitudinal study of children with a high risk for schizophrenia. Ment Hyg (1966) 0.76
Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res (2008) 5.99
Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res (2009) 3.68
Brain structures in pediatric maltreatment-related posttraumatic stress disorder: a sociodemographically matched study. Biol Psychiatry (2002) 2.74
Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol (2005) 2.49
Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophr Res (2010) 2.47
Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry (2012) 2.33
Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcohol Clin Exp Res (2005) 2.16
Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull (2003) 2.04
Platypnea-orthodeoxia syndrome: a diagnostic challenge. South Med J (2009) 1.85
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry (2013) 1.85
Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry (2010) 1.80
Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry (2013) 1.76
An MRI study of increased cortical thickness in autism. Am J Psychiatry (2006) 1.72
Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schizophr Res (2008) 1.71
Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv (2009) 1.62
Increased frontal cortical folding in autism: a preliminary MRI study. Psychiatry Res (2004) 1.58
Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry (2009) 1.56
Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test. Schizophr Bull (2008) 1.56
MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res (2003) 1.54
Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Arch Gen Psychiatry (2006) 1.43
Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry (2013) 1.43
Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett (2002) 1.39
Cross-sectional study of abnormal amygdala development in adolescents and young adults with bipolar disorder. Biol Psychiatry (2004) 1.38
Protected carotid artery stenting in patients at high risk for carotid endarterectomy. South Med J (2011) 1.38
Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophr Bull (2009) 1.36
Deconstructing psychosis with human brain imaging. Schizophr Bull (2007) 1.35
Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry (2013) 1.35
A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr Bull (2003) 1.34
Smaller cingulate volumes in unipolar depressed patients. Biol Psychiatry (2006) 1.33
A preliminary longitudinal magnetic resonance imaging study of brain volume and cortical thickness in autism. Biol Psychiatry (2009) 1.33
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal (2011) 1.32
Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biol Psychiatry (2013) 1.31
Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia. Schizophr Res (2004) 1.30
Sex differences in brain maturation in maltreatment-related pediatric posttraumatic stress disorder. Neurosci Biobehav Rev (2003) 1.28
Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry (2004) 1.26
Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res (2004) 1.26
Cingulate cortex anatomical abnormalities in children and adolescents with bipolar disorder. Am J Psychiatry (2005) 1.23
Anatomical MRI study of borderline personality disorder patients. Psychiatry Res (2004) 1.23
Disruption of orbitofrontal cortex laterality in offspring from multiplex alcohol dependence families. Biol Psychiatry (2008) 1.21
Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting. Catheter Cardiovasc Interv (2004) 1.20
An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res (2008) 1.20
Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry (2004) 1.20
Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr Bull (2004) 1.19
Motor performance and anatomic magnetic resonance imaging (MRI) of the basal ganglia in autism. J Child Neurol (2003) 1.19
Insight and frontal cortical function in schizophrenia: a review. Schizophr Res (2006) 1.18
"Just the facts": meandering in schizophrenia's many forests. Schizophr Res (2011) 1.18
Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial. Schizophr Bull (2012) 1.17
Measurement of the orbitofrontal cortex: a validation study of a new method. Neuroimage (2003) 1.17
Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects. Schizophr Res (2006) 1.16
Corpus callosum volume in children with autism. Psychiatry Res (2009) 1.16
Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. Am J Psychiatry (2004) 1.16
Superior temporal gyrus volumes in maltreated children and adolescents with PTSD. Biol Psychiatry (2002) 1.14
Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia. Psychol Med (2006) 1.13
Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? Schizophr Bull (2008) 1.12
Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study. J Affect Disord (2008) 1.09
Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia. PLoS One (2010) 1.09
Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.08
Cognitive training in mental disorders: update and future directions. Am J Psychiatry (2014) 1.07
Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study. Schizophr Res (2008) 1.07
Prefrontal subregions and dimensions of insight in first-episode schizophrenia--a pilot study. Psychiatry Res (2005) 1.06
Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.06
Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia. Biol Psychiatry (2005) 1.05
Corpus callosum volume and neurocognition in autism. J Autism Dev Disord (2009) 1.04
Volumetric alterations of the orbitofrontal cortex in autism. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.04
Insight and prefrontal cortex in first-episode Schizophrenia. Neuroimage (2004) 1.03
Native quadruple-valve endocarditis caused by Enterococcus faecalis. Tex Heart Inst J (2004) 1.03
Dorsolateral prefrontal cortex morphology and short-term outcome in first-episode schizophrenia. Psychiatry Res (2005) 1.03
Magnetic resonance imaging study of corpus callosum abnormalities in patients with bipolar disorder. Biol Psychiatry (2003) 1.02
The entorhinal cortex in first-episode psychotic disorders: a structural magnetic resonance imaging study. Am J Psychiatry (2004) 1.02
Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder. Biol Psychiatry (2012) 1.02
Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia. Schizophr Res (2010) 1.02
Reduced cortical folding in individuals at high risk for schizophrenia: a pilot study. Schizophr Res (2004) 1.02
Superior temporal gyrus volumes in pediatric generalized anxiety disorder. Biol Psychiatry (2002) 1.02
Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res (2003) 1.01
Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia. Biol Psychiatry (2007) 1.01
Anatomical MRI study of subgenual prefrontal cortex in bipolar and unipolar subjects. Neuropsychopharmacology (2002) 1.01
Multivariate prediction of emerging psychosis in adolescents at high risk for schizophrenia. Schizophr Res (2012) 1.01
One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia. Schizophr Res (2010) 1.00
1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology (2004) 0.99
Subgenual prefrontal cortex of child and adolescent bipolar patients: a morphometric magnetic resonance imaging study. Psychiatry Res (2005) 0.99
Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia. Biol Psychiatry (2008) 0.99
Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome. Neuroimage (2004) 0.99
Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression. Psychiatry Res (2009) 0.98
Magnetic resonance imaging study of the orbitofrontal cortex in autism. J Child Neurol (2006) 0.98
Abnormal brain size effect on the thalamus in autism. Psychiatry Res (2006) 0.98
1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord (2005) 0.98
Sex difference in cognitive response to antipsychotic treatment in first episode schizophrenia. Neuropsychopharmacology (2007) 0.98
Differential processing of metacognitive evaluation and the neural circuitry of the self and others in schizophrenia: a pilot study. Schizophr Res (2010) 0.97
Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. Am J Psychiatry (2005) 0.97
A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome. Res Dev Disabil (2013) 0.96
Effects of Cognitive Enhancement Therapy on Employment Outcomes in Early Schizophrenia: Results From a Two-Year Randomized Trial. Res Soc Work Pract (2011) 0.96
Spatiotemporal and frequency domain analysis of auditory paired stimuli processing in schizophrenia and bipolar disorder with psychosis. Psychophysiology (2011) 0.96
Anatomical MRI study of corpus callosum in unipolar depression. J Psychiatr Res (2004) 0.96
Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder? Schizophr Res (2010) 0.96
Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. Am J Psychiatry (2011) 0.94
Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction. Schizophr Bull (2013) 0.94
Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome. Psychiatry Res (2010) 0.94
Disordered corticolimbic interactions during affective processing in children and adolescents at risk for schizophrenia revealed by functional magnetic resonance imaging and dynamic causal modeling. Arch Gen Psychiatry (2012) 0.93